ALPS Advisors »

4d Molecular Therapeutics In shares owned by ALPS Advisors

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by ALPS Advisors from 13F filings

Historical chart of ALPS Advisors investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by ALPS Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by ALPS Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $588k 29k 20.26
2022-09-30 $142k 18k 8.04
2022-06-30 $134k 19k 7.00

More positions owned by ALPS Advisors

Energy Transfer Com Ut Ltd Ptn (ET)
Western Midstream Partners L Com Unit Lp Int (WES)
MPLX Com Unit Rep Ltd (MPLX)
Enterprise Products Partners (EPD)
Plains All Amern Pipeline L Unit Ltd Partn (PAA)
Sunoco Lp/sunoco Fin Corp Com Ut Rep Lp (SUN)
Enlink Midstream Com Unit Rep Ltd (ENLC)
Nustar Energy Unit Com (NS)
Hess Midstream Cl A Shs (HESM)
Cheniere Energy Partners Com Unit (CQP)
Cameco Corporation (CCJ)
Genesis Energy Unit Ltd Partn (GEL)
Usa Compression Partners Comunit Ltdpar (USAC)
Suburban Propane Partners L Unit Ltd Partn (SPH)
Global Partners Com Units (GLP)

View all positions for ALPS Advisors

Top funds holding 4d Molecular Therapeutics In

Viking Global Investors
RA Capital Management
BVF
VR Adviser
Henderson Group
Vanguard Group
Arrowpoint Asset Management
Casdin Capital
Goldman Sachs Group
Dimensional Fund Advisors
Deutsche Bank Aktiengesellschaft
Eagle Health Investments
Assenagon Asset Management
Jpmorgan Chase & Co
Point72 Asset Management

View all funds holding 4d Molecular Therapeutics In